Bristol-Myers Squibb's flurry of dealmaking has continued with en expansion of its partnership with BridgeBio on drugs targeting SHP2, in the hope of combining them with its cancer immunotherapy ...
Bristol Myers Squibb has moved to take full control of the CAR-T therapy it partners with 2seventy bio, agreeing to buy the biotech for around $286 million. The $5.00-per-share offer – announced at ...
New students join the Bentley community in both the fall and spring semesters. Regardless of when you start, you will have a robust New Falcon Experience. Along the way, there are tasks that you will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results